Since JAK2 was regulated by IL13Rα2 and type II IL4Rα and IL13Rα1 complex, we tried to screen an FDA-approved drug library with a JAK2 kinase assay kit to identify the novel candidates that were possibly inhibiting JAK2 in RCC cells. The gene discussed is IL13RA2; the disease is renal cell carcinoma.